Answers - Real Estate

1. Many homeowners do not fully understand the ramifications of and Adjustable Rate Mortgage. Too many borrowers a

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

pply for and obtain new mortgages that replace an existing fixed-rate loan with an ARM, yet they do completely comprehend

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

he potential payment scenarios that exist within their new contract. Many borrowers are enticed to refinance by the promi

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

e of lower monthly payments, but they fail to look at the long-term financial changes that could occur in their payments,

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

hich could potentially negate the perceived benefits of the refinance.

2. Many homeowners do not take the time to rese

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

rch all of their options when searching for a new mortgage. Often times there are multiple loan contracts that presen

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

different scenarios that could benefit the borrower, but without a comprehensive comparative analysis there is the possib

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

lity that the new mortgage was not the best choice in the long run for the homeowner.

3. Too many homeowners go into a

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

refinance situation without fully comprehending the additional costs associated with a new loan. They are then unplea

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

antly surprised to learn that there are significant out-of-pocket expenses or additional fees that are added to the new lo

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

n. It is essential that the borrower calculate these additional costs and ensure that the added expenses are legitimate a

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

d still make the refinance a good decision.

4. Many homeowners refinance their existing mortgages for poor reasons.
dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod
A significant number of lenders will offer the option for borrowers to refinance with additional cash taken from the equ
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
ty of the property. When the cash out is the primary reason for the refinance in the first place, it is absolutely impera
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
ive that the homeowner consider the intended uses for the equity proceeds and determine whether or not it makes sense in t
t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
e end to utilize equity.

5. Many homeowners are under the misconception that they will obtain the best refinance deal
ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust
y going through their existing mortgage lender. This is not always the case. Just because the lender already has the
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
borrower’s information, there is no guarantee that this particular lender has the best available loan programs, nor is it
.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
guarantee that the borrower will be required to undergo a less strenuous application process. With the number of lenders
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip
available, it always makes sense for the borrower to research multiple companies before choosing which one to proceed with

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

Tags

Links

Answers - 5 Refinancing Mistakes to Avoid

Related Articles: